Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.
Both incident and recurrent heart failure hospitalization risk is associated with post-traumatic stress disorder among patients with CAD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback